Dr Laage has published articles on urinary tract infection and treatment-resistant anxiety and depression. He has practiced psychiatry for many years, teaching residents and medical students at the McLean Hospital and Harvard Medical School. He now consults to medical communications companies and clinical trials and does executive coaching. Dr Laage joined the Edanz Group as an editor and writer in 2010.

Dr Creasey is a senior post-doctoral fellow in the laboratory of Dr Paul Hunt, University of Edinburgh (genetics of artemisinin drug resistance in a rodent malaria model). Her special interests have been in the field of tropical medicine and tropical parasitic diseases, with training in the epidemiological aspects of disease. Her field experience in serology and microbiology involved a number of anti-parasitic drug trials in Africa. Later in Edinburgh, genetics and molecular biology were focused on. Dr Creasey has the ability to communicate science in clear, unambiguous language. During her career she has edited journal articles and PhD theses for scientists from China, Thailand, Sri Lanka, Saudi Arabia, and most African countries. Dr Creasey joined Edanz Editing as an editor in 2007.

Dr Curtis’s PhD thesis was entitled “Neural Progenitor Cells in Huntington’s Disease Human Brain.” He is currently a Post-doctoral Research Fellow studying neurodegenerative disorders. Dr Curtis has authored many published reports in several leading international journals including the cover article for an issue of Science in 2007. He has given invited lectures in several countries, presenting topics associated with the field of neurology. Dr Curtis began editing for Edanz Editing in early 2006 and works in a very broad area of the biomedical sciences, applying his extensive knowledge of laboratory and imaging procedures.

Dr Devon is a biologist with a special interest in neuroscience and genetics. She is a graduate of the University of Cambridge, United Kingdom, and obtained her PhD in 1996 from the University of Edinburgh, UK, in the genetics of psychiatric illness. She undertook post-doctoral research on a rare, inherited form of Motor Neurone Disease (Lou Gehrig's Disease) in Vancouver, Canada, and then started her own research group back in Edinburgh, UK, investigating the genetics, cell biology and biochemistry of motor neurone disease. She is a co-founder of the Euan MacDonald Centre for Motor Neurone Disease Research at the University of Edinburgh. Dr Devon has written over 50 research papers, book chapters, reviews and successful grant applications, and has peer-reviewed manuscripts for molecular biology journals. Dr Devon began working with Edanz Editing in 2008.

Dr Demarest received a BSc in Psychology and a PhD in Neurobiology and Behavior from the State University of New York at Stony Brook. Her work has focused on the neuroscience and genetics of a behavioral mouse model. From her research she has authored several peer-reviewed papers. She is currently a staff scientist at the Scripps Research Institute. She joined the Edanz Group as an editor in 2008.

Dr McGowan has won many awards during his career, including in 2003 the EU Marie Curie Post-doctoral Fellowship. He has worked in laboratories investigating the molecular mechanisms in Parkinson’s disease as well as those involved in Huntington’s disease, combining laser micro-dissection, microarray analysis and proteomics. Further study involved micro-array gene expression analysis of molecular processes occurring during normal aging and how these are affected by mental exercise. Dr McGowan has an in-depth knowledge of neurodegenerative diseases, neural function, marine zoology, molecular and cellular biology and protein biochemistry, along with extensive multi-disciplinary laboratory experience of contemporary and traditional techniques including proteomics, functional genomics and cell imaging. His excellent written and oral communication skills are demonstrated by several first author publications. From 2005 to October 2006, Dr McGowan was an Associate Editor at Nature Reviews Neuroscience before becoming a full-time editor for Edanz Editing. Dr McGowan is the Edanz Group Science Director.

Dr Allen is a biologist with particular experience in the fields of neuroscience, developmental biology and genetics. His PhD topic involved molecular genetic analysis of mouse mutations that affect limb development. From 1996 to 2004, Dr Allen was a researcher at the Department of Neurobiology, Babraham Institute, Cambridge, UK. Dr Allen’s research skills and techniques include DNA/RNA manipulation and purification/isolation, electrophoreses, PCR, cloning, all blottings, library screening, genetic mapping, design and construction of transgenes, artificial chromosome engineering, design and construction of vectors for gene targeting in ES cells, cell culture, histological techniques, mouse behavioral analysis, small animal surgery, and bioinformatic tools such as sequence databases and analysis tools. Dr Allen began working with Edanz Editing as an editor in fields associated with neuroscience and genetics in 2007.

Dr Mahkdum was a Research Fellow at the University College London before becoming a Post-doctoral Research Fellow at the Scripps Institute at the University of California, San Diego, in California. Since 2000, Dr Makhdum has been a medical writer and editor holding various positions including Managing Editor at Elsevier in Oxford from 2005 to 2007. Dr Makhdum began as an editor with Edanz Editing and Liwen Bianji (Edanz Editing China) in 2008.

Dr Donkin's PhD thesis was entitled "The Effects of the Neuropeptide Substance P on Outcome Following Traumatic Brain Injury in Rats". His research interests include developing novel pharmacotherapeutic agents for the treatment of neurotrauma and neurodegeneration using rodent animal models. He has completed a post-doctoral fellowship at the University of British Columbia, Canada, investigating potential prophylactic and therapeutic compounds in the prevention and treatment of Alzheimer's disease. Dr Donkin has published several peer-reviewed journal articles and currently works as a scientific writer. Dr Donkin joined the Edanz Group as a science editor, writer and reviewer in 2011.

After obtaining a BA and PhD in zoology from the University of Oxford, Dr Prosser joined the Medicine Publishing Company, Abingdon, UK, (now part of Elsevier Health Sciences) as a Staff Editor of medical educational publications. In 1998, she became Managing Editor of the journal Medicine, a position she held until 2006, when she began as a freelance science and medical writer and manuscript editor. Dr Prosser, an accomplished and highly experienced biomedical and health sciences editor and writer, began working with Edanz Group in 2006.

Dr Bradshaw is a clinical specialist with a strong background in biomedical science and healthcare related research. He is a member of the European Medical Writers Association (EMWA), and has published over 17 scientific papers. In 2007/8, Dr Bradshaw sat on the board as an elected member of both the Royal College of Physicians guideline development and steering groups, leading to the publication of National Health Service guidelines. He also first-authored the UK national guidelines on “Occupational Visual Standards” for the Royal College of Ophthalmologists. He is a peer reviewer for several top journals including: the American Journal of Ophthalmology, Aviation Space and Environmental Medicine and the British Journal of General Practice. Dr Bradshaw is a specialist editor across a wide variety of medical and bioscience topics. He joined the Edanz Groups as an editor and writer in 2010.

Dr Davies is a biologist with particular expertise in the areas of neuroscience, oncology, and chromatin structure and gene expression. Dr Davies has held Postdoctoral Fellow positions at a number of institutes including the François Magendie Institute for Neuroscience, Bordeaux, France, and the Children’s Cancer Institute Australia. During his PhD, he examined chromatin structure and cisplatin damage at the human beta-globin gene cluster. Dr Davies has been a regular reviewer for several international journals and has edited numerous manuscripts written by both native and non-native English speakers. He has a number of first-author publications in journals such as Nucleic Acids Research and The Journal of Pharmacology and Experimental Therapeutics. Dr Davies has experience in a wide variety of laboratory techniques, including acute and organotypic culture, adenovirus manipulation, lentivirus manipulation and transduction of brain slices and cultured neuronal cells, fluorescent and confocal microscopy, cell microinjection, in vivo mouse models, western blot, electrophoretic gel mobility shift assay, PCR (most varieties), cloning and bacterial plasmid production. Dr Davies began working as an editor for Edanz Editing in 2006.

Dr Kuhn has extensive experience as a research scientist and is well published as a first author. She began as an editor for Edanz Editing in 2007 and edits in fields associated with neuroscience, physiology, brain rehabilitation/repair, postnatal and adult neurogenesis, memory, learning, neurodegenerative disease, stem cells, molecular biology, including PCR, cloning, subcloning, subtractive hybridization, plasmid preparation/purification, cDNA, RNA, and genomic DNA purification. She also has working experience with all associated laboratory tests and skills necessary for that environment.

Dr Mosi’s PhD studies involved the mechanism of reaction of two alpha glycosyltransferases, glycogen phosphorylase and cyclodextrin glycosyltransferase, through the use of modified substrates and inhibitors. Dr Mosi is a senior research scientist with eight years’ experience in pharmaceutical drug research. She has developed and implemented novel assays for the purpose of the identification of inhibitors of metallo-enzymes as antibacterials and inhibitors of cysteine proteases for the treatment of cancer. Dr Mosi has applied expertise in enzymology, receptor based cell biology, drug metabolism and protein purification and production. As well, she has designed and standardized systems and procedures for interpreting scientific results. She also has a sound knowledge of FDA guidelines and is trained in GLP and GMP procedures. Dr Mosi is a past member of the Drug Information Association, International Society for the Study of Xenobiotics, Society for Biomolecular Screening, American Society of Microbiology, and the Canadian Society of Chemistry. As first author of 10 published, peer reviewed manuscripts, and as editor of numerous other papers in fields of biology, biochemistry, chemistry and pharmacology, Dr Mosi brings an extensive writing background to her editing work for Edanz Editing.

Dr Patel is a neuroscientist interested in central nervous system degeneration and mental illness. For his doctoral thesis he developed a mouse gene-knockout model for the human neurological disorder aceruloplasminemia. Subsequently, as a research fellow at the Department of Cell Biology at Harvard Medical School he studied the molecular signaling cascades involved in nerve cell migration. Dr Patel has recently focused his research on the molecular genetics of psychiatric illness as an associate at the Douglas Mental Health Institute in Montreal. His studies center on microRNA signaling networks involved in major depression and suicide. Dr Patel has published a number of first-author articles in high-impact journals, including The Journal of Biological Chemistry and The Journal of Neuroscience. He began editing for the Edanz Group in 2011.

Dr Reynolds initially practiced in Medical Oncology and then Psychotherapy. After retiring from clinical practice in 2003 she began a new career in medical editing. Most of her work has been for Japanese and Chinese authors. A successful author, Dr Reynolds has published 13 articles in peer-reviewed journals, and two books. Dr Reynolds joined the Edanz Group as an editor and writer in 2011 and, though with a clinical focus, works in a broad range of medical fields.

Ms Schatken’s university studies focused on medical technology. After graduation she worked for six years in specialized hematology and research laboratories: the Albany (NY) Medical Center, Mallory Institute (Boston), Tufts Medical School (Boston), Upstate Medical Center (State University of New York, Syracuse, NY), and the Jewish Medical Center (New York). She then went into medical publishing at Harper & Row, later moving to the magazine Medical World News. In 1970 she began working as an independent medical editor and writer. Her work has included preparing reports for physicians, pamphlets/booklets for pharmaceutical houses, abstracts of medical articles, and conference presentations. She has also copyedited medical and scientific journals and books for a variety of publishers, including Springer (New York and Tokyo), Oxford University Press, Little Brown, Raven Press, Harper & Row, Appleton-Century Crofts, and Churchill Livingstone. Ms Schatken began working as an editor and writer with the Edanz Group in 2010.

Dr Bijur's work is on neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, and investigations into brain metabolic functions. Dr Bijur has extensive experience in the areas of psychiatry, including schizophrenia and bipolar disorder, metabolic disorders such as diabetes, and in oncogenesis and carcinogenesis. He has thorough understandings of cell culture techniques, molecular biology techniques, and rodent animal models. His personal research has been funded by the U.S. National Institutes of Health and the National Alliance for Research on Schizophrenia and Depression. Dr Bijur has authored over 32 peer-reviewed publications, and has presented at numerous scientific conferences including the Society for Neuroscience and the American Association for Cancer Research, among others. He also serves as a reviewer for several biomedical journals and granting agencies. Dr Bijur joined the Edanz Group as an editor and medical writer in 2010.

Currently, Dr Werry is at Queen Mary University of London studying dentistry. Prior to this, he worked for GlaxoSmithKline Ltd in the Neurosciences Centre of Excellence in Drug Discovery in Harlow, UK. Dr Werry studied G protein-coupled receptor (GPCR) pharmacology and cellular signaling as part of his PhD in a thesis entitled "The effects of crosstalk on GPCR-mediated calcium signaling pathways". He has also worked in one of the premier pharmacology labs in the world with Prof Arthur Christopoulos at Monash University, Melbourne, Australia, studying cellular signaling by variants of the serotonin 5HT2C receptor and the pharmacology and cell biology of mitogen-activated protein kinase signaling. Dr Werry's work has produced numerous publications including original research papers and authoritative reviews on calcium and ERK signaling and 5HT2C receptor RNA editing. His areas of expertise include pharmacology, neuroscience, G protein-coupled receptors, and cellular signaling. Dr Werry began working with the Edanz Group as a writer and editor in 2010.

Dr Byrne’s PhD studies in neuroanatomy and neuropharmacology have centered on the role of oxidative stress in neurodegenerative diseases. In her research she investigated the expression and activity of the pro-oxidant enzyme, myeloperoxidase, in post-mortem human brain tissue and in cellular models of neurofibrillary pathology. She has published two papers in international peer-reviewed journals and is currently a teaching fellow in human biology at the University of Otago, New Zealand. She began working as an editor for the Edanz Group in 2010.

Ms Malapetsas is a medical and scientific editor/writer with experience in the development of content in the various areas in the life sciences for both medical research institutes and pharmaceutical advertising agencies. Initially a research assistant in a cancer research laboratory at the Lady Davis Institute for Medical Research in Montreal, Canada, she performed molecular and cellular biology experiments—including mRNA, DNA, and protein extraction and purification, Northern and Western blots, RT-PCR, cellular transport, primary tissue culture, and various drug efficacy studies. She also developed laboratory documents for submission to journals and funding agencies. Ms Malapetsas then worked in pharmaceutical advertising, where for eight years she undertook proofreading, copyediting, and fact-checking, and wrote medical education programs delivering on-label drug information to physicians and healthcare professionals. Ms Malapetsas also has extensive experience as a freelance medical and scientific editor/writer for research laboratories and corporate entities. Ms Malapetsas began working as an editor with the Edanz Group in 2009.

Dr James’ PhD thesis, and initial postdoctoral work, was on the characterization of DISC1, a susceptibility gene for psychiatric illness. Subsequent postdoctoral research focused on acute brain injury and the mitochondrial response in a transgenic mouse model. Dr James understands brain biology with a particular interest in psychiatric illness, neurodegenerative disease, genetics and cellular biology. She has multi-disciplinary laboratory expertise in a number of techniques, covering protein biochemistry, cellular and molecular biology, histology and microscopy. Dr James has experience of human tissue studies, as well as transgenic animal models and cell culture systems, including embryonic stem cells. From her research she has co-authored several peer-reviewed papers, including a Science paper, which was cited as one of the top ten breakthroughs of 2005. Dr James joined the Edanz Group as an editor in 2011.

Dr Eve McCutchen Vick's research has included studies of hippocampal synaptic plasticity, degeneration of hippocampal cholinergic innervation, and modulation of neuronal signaling by neurotrophic factors. Her expertise includes learning and memory, synaptic plasticity, hippocampal physiology and intracellular signaling, cholinergic and adrenergic receptors, electrophysiology and immunohistochemistry. Dr Vick is well published in high-ranking journals, and has edited manuscripts across a variety of subject areas, including neuroscience, pharmacology, toxicology, and cardiology. She has also taught undergraduate courses in both Psychology and Anatomy and Physiology at several institutions in the US. Dr Vick joined the Edanz Group as an editor in 2011.

Dr Steen’s experience is related to anything to do with the brain; from human behavior to molecular biology and everything in between. He has done brain imaging research, using MRI to study pediatric stroke (particularly hematologic and genetic risk factors for stroke). Dr Steen has held Associate Professor positions in Psychiatry, as well as in Radiology, Pediatrics, and Biomedical Engineering. He has published 80 papers in refereed scientific literature, as well as 6 books and many book chapters. His specialties are brain imaging and clinical neurology, but Dr Steen has also written in the fields of epidemiology, genetics, exercise physiology, psychology, allergy, cardiology, sleep medicine, pulmonology, orthopedics, research ethics, and even invertebrate zoology. Dr Steen joined the Edanz Group as a writer and editor in 2010.

Dr Murnane is a biologist with particular experience in neuroscience and pharmacology. His PhD dissertation topic was an examination of the in vivo pharmacology of methylenedioxymethamphetamine (MDMA, “ecstasy”). Dr Murnane is currently a post doctoral fellow at Emory University, Atlanta, Georgia, the United States. He has received numerous prestigious honors and awards for his research. Dr Murnane is a member of the Society for Neuroscience, the College on Problems of Drug Dependence, and the American Society for Pharmacology and Experimental Therapeutics. His present research interests include studying the in vivo effects of psychostimulants using behavioral pharmacology, neurochemistry, and neuroimaging techniques. Dr Murnane also has significant experience in the fields of addiction, depression, anxiety, schizophrenia, cognition, comparative psychology, and animal behavior. In 2010 he joined Edanz Group, where he applies his research background and expertise as a writer and editor to assist clients achieve their publication goals.

Dr Cornforth is a Naturopathic Physician with over six years of medical writing and scientific editing experience. Her areas of clinical expertise include herbal medicine, nutrition, endocrinology, and women's health. She has also worked as a health informatics consultant analyzing published research and building risk analysis software. Dr Cornforth is a member of the American Medical Writers Association. Dr Cornforth began working with the Edanz Group as an editor in 2010.

Dr Aprico's doctoral thesis was "[3H]4-methylglutamate as a novel radioligand for the brain glutamate transporters." From 2003 to 2005, Dr Aprico held a post-doctoral position at Arvid Carlsson Institute, Göteborg, Sweden, working with Dr Michael Nilsson, investigating in vitro models of reactive astrogliosis. Since 2005, Dr Aprico has been a university lecturer in pharmacology and physiology, but returned to university to obtain her medical degree in mid-2009. Dr Aprico began as an editor with the Edanz Group in 2008.

Ms Koke is presently in the Psychology and Neuroscience PhD program at Duke University in Durham, North Carolina, U.S.A. Her research interests include the neurological mechanisms of time and rhythm perception, motor rhythm synchronization and therapeutic brain stimulation. Previously, Ms. Koke worked as a research associate at the University of Calgary in the Behavioural Neuroscience Research Group and then as a member of the Hotchkiss Brain Institute in various research labs; studies included epilepsy, circadian rhythms, learning and memory, and therapeutic brain stimulation. She has experience with behavioral training and stereotaxic surgery in both rodent and primate models. Ms Koke has 5 years of research experience in the fields of behavioral neuroscience and clinical neuroscience; publishing two papers in international peer-reviewed journals. Ms Koke joined the Edanz Group as an editor in 2010.

Ms Fried, a qualified pharmacist, is a medical editor with more than 20 years’ editing experience. She has edited articles in a range of fields with special interest in general medicine, gastroenterology, gastric cancer, rheumatology, health and life sciences. Ms Fried was also an in-house copy editor in Springer Verlag’s Tokyo office. In Tokyo, she edited books in various medical fields for Springer Verlag and for the University of Tokyo Press. She has also been a trainer for business-writing. Ms Fried joined the Edanz Group as an editor in 2011.